Search results for "Vaccines"
New vaccine authorization and data, NIH on antibody treatment and ‘long COVID’
The Johnson & Johnson COVID-19 vaccine got an emergency use authorization, and an Israeli study provided more data on the Pfizer vaccine. The NIH recommended an antibody combo for outpatients and named long-term symptoms as post-acute sequelae of SARS-CoV-2 (PASC).
https://immattersacp.org/weekly/archives/2021/03/02/1.htm
2 Mar 2021
Research, news about COVID-19 vaccines, resources from ACP on flu vaccination
Results of vaccine trials were positive, but concerns arose about safety.
https://immattersacp.org/weekly/archives/2020/09/15/1.htm
15 Sep 2020
Remain vigilant this ‘twindemic’ season
The CDC is anticipating a resumption of seasonal flu activity in the U.S., but the potential effects of the COVID-19 pandemic this year remain unknown.
https://immattersacp.org/archives/2021/10/remain-vigilant-this-twindemic-season.htm
1 Oct 2021
New authorization, guidance on vaccines against SARS-CoV-2
The Moderna COVID-19 vaccine was authorized by the FDA and recommended by the CDC, additional guidance was issued on the use of the Pfizer-BioNTech vaccine, and ACP and Annals of Internal Medicine held a forum on encouraging vaccine uptake.
https://immattersacp.org/weekly/archives/2020/12/22/1.htm
22 Dec 2020
Research on COVID-19 vaccines' duration, reactions, prioritization
Antibodies persisted six months after vaccination, and a graded dosing protocol allowed patients with reactions to a first shot to get a second. Surveyed Americans wanted to prioritize front-line workers and those with chronic conditions for vaccination, and a columnist finds reasons for hope.
https://immattersacp.org/weekly/archives/2021/04/13/1.htm
13 Apr 2021
The waning and boosting of COVID-19 immunity
ACP and Annals of Internal Medicine's sixth COVID-19 forum examined progress amid the pandemic in the past year.
https://immattersacp.org/archives/2021/11/the-waning-and-boosting-of-covid-19-immunity.htm
1 Nov 2021
Studies assess responses, reactions to vaccines; long-term effects of COVID-19 infection
Recent COVID-19 vaccine studies showed good response in pregnant women, as well as possible localized rashes from the Moderna vaccine. Analyses of ICU patients and those treated at a post-COVID-19 clinic highlighted the long-term effects of the virus, and a study found that dialysis patients maintained antibodies six months after COVID-19 infection.
https://immattersacp.org/weekly/archives/2021/05/18/1.htm
18 May 2021
Clot concerns with adenovirus COVID-19 vaccines, antibody treatment recommendations and data
Based on reports of cerebral venous sinus thrombosis with the Johnson & Johnson (Janssen) COVID-19 vaccine, federal officials recommended a pause in its use, which will be reconsidered on April 23. The NIH updated its recommendations on monoclonal antibody treatments for outpatients.
https://immattersacp.org/weekly/archives/2021/04/20/1.htm
20 Apr 2021
Expensive vaccines may wipe out wrong target—the doctor
New and expensive vaccines added to the schedule for adolescents, adults and children over the last several years have created a crisis in the delivery system that threatens to reduce or eliminate the private provider's role, say experts following the issue.
https://immattersacp.org/archives/2009/04/vaccine.htm
1 Apr 2009
Postexposure prophylaxis drug, vaccine complications, and anticoagulation in COVID-19
A monoclonal antibody combination was effective for postexposure prophylaxis and received emergency use authorization. A study investigated postvaccine myocarditis and pericarditis, and effects of full-dose anticoagulation differed by whether patients were critically ill.
https://immattersacp.org/weekly/archives/2021/08/10/1.htm
10 Aug 2021